Indication
Secondary Immune Deficiency
2 clinical trials
2 products
Clinical trial
Facilitated Immunoglobulin Administration Registry and Outcomes StudyStatus: Completed, Estimated PCD: 2021-11-30
Product
HyQviaClinical trial
Safety, Tolerability, and Patient Satisfaction of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment by Rapid Push in Patients With Primary or Secondary Immunodeficiency (PID or SID)Status: Recruiting, Estimated PCD: 2024-06-01
Product
Cutaquig®